SCHEMBL29028876

SCHEMBL29028876

O=C(O)c1nc(Cl)c(C(F)(F)F)cc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ TXNRD1 Q16881 1/20 0.41
▸ TXNRD3 Q86VQ6 1/20 0.41
▸ TXNRD2 Q9NNW7 1/20 0.41
▸ AR P10275 4/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ CES2 O00748 1/20 0.39
▸ ABCB11 O95342 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29381761 0.85 AR (0.42) CYP3A4ALDH1A1ALOX15TSHRTDP1
SCHEMBL24241065 0.85 AR (0.42) CYP3A4ALDH1A1ALOX15TSHRTDP1
SCHEMBL8975900 0.84 ALDH1A1 (0.49) CYP3A4ALDH1A1ALOX15TSHRTDP1
SCHEMBL29028923 0.84 AR (0.40) CYP3A4ALDH1A1ALOX15TSHRTDP1
SCHEMBL7585436 0.80 VCAM1 (0.41) CYP3A4ALDH1A1TSHRTDP1LMNA
SCHEMBL24241353 0.78 KMO (0.40) ALDH1A1TDP1HPGDLMNAGLA
SCHEMBL8976064 0.77 ALDH1A1 (0.45) CYP3A4ALDH1A1ALOX15TSHRTDP1
SCHEMBL3639455 0.76 ASPH (0.44) ALDH1A1TDP1HPGDKMT2AMEN1
SCHEMBL14783265 0.75 CFTR (0.46) TDP1KMT2AMEN1
SCHEMBL29060149 0.74 HDAC6 (0.41) CYP3A4ALDH1A1ALOX15TSHRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4247817-A1 MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-09-27 — — EP disclosed
CN-116670140-A Macrocyclic compounds containing 1,3, 4-oxadiazole rings as modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-08-29 — — CN disclosed
EP-4192829-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-06-14 — — EP disclosed
CN-116171154-A Modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-05-26 — — CN disclosed
WO-2022109573-A1 MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-05-27 — — WO disclosed
WO-2022032068-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-02-10 — — WO disclosed
Send feedback